HOXA9 and chronic myelogenous leukemia, BCR-ABL1 positive: We therefore hypothesize that miR-196b acts as a tumor suppressor in CML, via the up-regulation of BCR-ABL1 and HOXA9. We have also investigated the role of epigenetic regulation in the decreased expression of miR-196b in CML.